Is a complete SHE/301211 research report available?

No complete published report is available for she/301211 (SHE/301211) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

she/301211 stock profile: metrics, valuation and analysis

Market cap	5B
Revenue (ttm)	466.1M
Net income (ttm)	46.5M
EPS (ttm)	CN¥0.12
Shares out	417.6M
P/E (trailing)	100.4x
Dividend	CN¥0.06 (0.51%)
Volume	2,030,200
Beta	0.54

All SHE/301211 indicators

Market & fundamental data

Available fields

224

Groups with data

Currency

CNY

Showing 224 of 224 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	China
Country code	CN
Employees	952
Employees Change	-35%
Employees Change Percent	-3.55
Enterprise value	CNY 3.4B
Exchange	Shenzhen Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Industry PE	35.39
Industry PE Fwd	17.7
Isin	CNE100005782
Last refreshed	2026-09-09
Market cap	CNY 5B
Price	CNY 11.69
Price currency	CNY
Rev Per Employee	489,552.77x
Sector	Healthcare
Sector PE	40.75
Sector PE Fwd	20.95
Sic	2833
Symbol	she/301211
Website	https://www.biocause.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	0.93%
EV Earnings	73.89x
EV/EBIT	222.93x
EV/EBITDA	56.08x
EV/Sales	7.37x
FCF yield	-0.59%
P/B ratio	2.18x
P/E ratio	100.43x
P/S ratio	10.67x
PE Ratio3 Y	81.13x
PE Ratio5 Y	70.88x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	3.31%
EBITDA Margin	12.82%
Gross margin	22.39%
Gross Profit	CNY 104.3M
Gross Profit Growth	15.23%
Gross Profit Growth Q	41.43%
Gross Profit Growth3 Y	-24.35%
Gross Profit Growth5 Y	-15.76%
Net Income	CNY 46.5M
Net Income Growth	11.78%
Net Income Growth Q	154.45%
Net Income Growth Qo Q	126.92%
Net Income Growth Quarters	1%
Net Income Growth Years	0%
Net Income Growth3 Y	-36.83%
Net Income Growth5 Y	-20.24%
Pretax Margin	11.62%
Profit Margin	9.98%
Profit Per Employee	CNY 48,844
Profitable Quarters	CNY 26
Profitable Years	9
ROA	0.4
Roa5y	2.2
ROCE	0.67
ROE	2.05
Roe5y	5.39
ROIC	1.78
Roic5y	16.25

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-6.14%
Cagr3y	-6.2%
Div CAGR3	-39.86%
EPS Growth	33.63
EPS Growth Q	231.9
EPS Growth Qo Q	161.4
EPS Growth Years	0
EPS Growth3 Y	-35.51
EPS Growth5 Y	-23.75
FCF Growth Q	474.23%
OCF Growth	-56.1%
OCF Growth Q	1,399.41%
OCF Growth3 Y	-46.31%
OCF Growth5 Y	-17.15%
Revenue Growth	6.22x
Revenue Growth Q	5.84x
Revenue Growth Qo Q	5.98x
Revenue Growth Quarters	3x
Revenue Growth Years	1x
Revenue Growth3 Y	-11.85x
Revenue Growth5 Y	-4.14x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CNY 0.19
Assets	CNY 2.4B
Cash	CNY 1.5B
Current Assets	CNY 1.8B
Current Liabilities	CNY 101.1M
Debt	CNY 1.9M
Debt EBITDA	CNY 0.03
Debt Equity	CNY 0
Debt FCF	CNY -0.07
Equity	CNY 2.3B
Interest Coverage	191.6
Liabilities	CNY 114M
Long Term Assets	CNY 607.2M
Long Term Liabilities	CNY 12.9M
Net Cash	CNY 1.5B
Net Cash By Market Cap	CNY 30.92
Net Cash Growth	-1.84%
Net Debt EBITDA	CNY -25.74
Net Debt Equity	CNY -0.67
Tangible Book Value	CNY 2.2B
Tangible Book Value Per Share	CNY 5.53
WACC	7.22

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	17.65
Inventory Turnover	2.83
Net Working Capital	CNY 145.3M
Quick ratio	16.04
Working Capital	CNY 1.7B
Working Capital Turnover	CNY 0.28

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	16.35%
Dividend Growth	-65.2%
Dividend Growth Years	0%
Dividend per share	CNY 0.06
Dividend Years	5
Dividend Yield	0.51%
Ex Div Date	2026-06-12
Last Dividend	CNY 0.06
Payout Frequency	Annual
Payout Ratio	53.88%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-6.13%
200-day SMA	12.1
3Y total return	-17.48%
50-day SMA	11.77
50-day SMA vs 200-day SMA	50under200
All Time High	32.33
All Time High Change	-63.16%
All Time High Date	2022-12-16
All Time Low	9.01
All Time Low Change	32.19%
All Time Low Date	2026-06-22
ATR	0.69
Beta	0.54
Beta1y	0.16
Beta2y	0.48
Ch YTD	-2.54
High	11.83
High52	16.95
High52 Date	2025-11-10
High52ch	-31.03%
Low	11.63
Low52	9.01
Low52 Date	2026-06-22
Low52ch	29.75%
Ma50ch	1.2%
Price vs 200-day SMA	-1.53%
RSI	49.05
RSI Monthly	48.27
RSI Weekly	51.61
Sharpe ratio	0.06x
Sharpe Ratio3y	-0.02x
Sortino ratio	0.22
Sortino Ratio3y	0.09
Total Return	16.86%
Tr YTD	-1.91
Tr1m	2.94%
Tr1w	-1.81%
Tr3m	22.31%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	167,323,100%
Net Borrowing	-1,402,643
Shares Insiders	14.75%
Shares Institutions	0.85%
Shares Out	417,600,000
Shares Qo Q	-13.19%
Shares Yo Y	-16.35%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	21,842,677.5x
Bv Per Share	5.69
CAPEX	CNY -61.2M
Ch1m	2.94
Ch1w	-1.81
Ch1y	-6.73
Ch3m	21.53
Ch3y	-21.4
Ch6m	-2.38
Change	-1.85%
Change From Open	-1.1
Close	11.91
Days Gap	-0.76
Depreciation Amortization	44,326,721
Dollar Volume	23,733,038
Earnings Date	2026-08-25
EBIT	CNY 15.4M
EBITDA	CNY 59.7M
EPS	CNY 0.12
F Score	6
FCF	CNY -29.4M
FCF EV Yield	-0.85x
FCF Per Share	CNY -0.07
Financing CF	-26,910,992
Fiscal Year End	December
Founded	1,995
Graham Number	3.89784
Graham Upside	-67.27
Income Tax	CNY 7.6M
Investing CF	-124,000,984
Is Primary Listing	1
Last Earnings Date	2026-08-25
Last Report Date	2026-06-30
Last Split Date	2025-08-27
Last Split Type	Forward
Lynch Fair Value	CNY 0.59
Lynch Upside	-95.02
Ma150	11.65
Ma150ch	2.28%
Ma20	12.39
Ma20ch	-3.84%
Net CF	-122,592,478
Next Earnings Date	2026-10-23
Open	11.82
P OCF Ratio	156.2
Payment Date	2026-06-12
Position In Range	30
Ppne	524,464,564
Price Date	2026-09-09
Price EBITDA	CNY 83.26
Ptbv Ratio	2.25
Relative Volume	0.09x
Revenue	466,054,237x
Tax By Revenue	1.64x
Tax Rate	14.1%
Tr6m	-1.75%
Volume	2,030,200

SHE/301211 (SHE/301211)

Price

Financial snapshot

Fair-value bridge

Latest news · SHE/301211

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All SHE/301211 indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on SHE/301211

Frequently asked questions